AI blood test detects early pancreatic cancer with up to 94% accuracy

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

Molecular target drives immunogenicity in cancer immunotherapy

Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as ...
Science Daily

MIT scientists strip cancer of its sugar shield

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...
EurekAlert!

Johns Hopkins investigators create open source database to more easily study cancer cells, patient experience on large scale

Researchers from the Johns Hopkins Kimmel Cancer Center and The Johns Hopkins University have created a novel database ...
News-Medical.Net on MSN

AI cancer tools may be using visual shortcuts rather than true biology

New research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals. Artificial intelligence tools are ...
Becker's Hospital Review

Cedars-Sinai AI tool predicts best chemotherapy for pancreatic cancer patients

Cedars Sinai tool predicts the best chemotherapy regimen for advanced pancreatic cancer using AI analysis of biopsy images.
eLife

Contractile peri-nuclear actomyosin network repositions peripheral and polar chromosomes to promote early kinetochore–microtubule interactions

This important study demonstrates that a peri-nuclear actomyosin network, present in some types of human cells, facilitates kinetochore-spindle attachment of chromosomes in unfavorable locations - ...